Abstract
We describe a simple method for characterizing a frequent polymorphism (that substitutes an arginine for a proline) in the coding sequence of the Tp53 gene in patients with colonic cancer and in a control population. We could find no evidence that this polymorphism is associated with a marked predisposition to colorectal cancer.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Base Sequence
-
Colonic Neoplasms / genetics*
-
Gene Frequency
-
Genetic Carrier Screening
-
Humans
-
Molecular Sequence Data
-
Oligonucleotide Probes
-
Polymerase Chain Reaction
-
Polymorphism, Genetic*
-
Rectal Neoplasms / genetics*
-
Reference Values
-
Tumor Suppressor Protein p53 / genetics*
Substances
-
Oligonucleotide Probes
-
Tumor Suppressor Protein p53